I don't think JCFraser has done anything wrong. We're all here to make money. No one is obligated to be loyal to the company. Might buy back in later. We'll see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025